A novel process for purification of human growth hormone
A technology of human growth hormone, hydrophobic interaction chromatography, applied in a new field for purification of human growth hormone
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0085] Addition of K to the ion-exchange purified fraction of hGH 2 HPO 4 The final concentration is 0.4M. Inject it onto a 1ml Resource phenyl column (30×6.4mm) with 20mM Na 2 HPO 4 / 0.4M K 2 HPO 4 , pH9.0 balance. Bind protein with 20ml linear gradient of 20mM Na 2 HPO 4 , pH 9.0 / 50% acetonitrile for elution. Fractions of 1 ml were collected and analyzed by SDS-PAGE. The clipped hGH molecules elute before intact GH molecules (Figure 1). Obtain human growth hormone in a highly pure form. (purity: >99.5%, yield: 85%)
Embodiment 2
[0087] Addition of K to the ion-exchange purified fraction of hGH 2 HPO 4 The final concentration is 0.4M. Inject it onto a 1ml Resource phenyl column (30×6.4mm) with 20mM Na 2 HPO 4 / 0.4M K 2 HPO 4 , pH9.0 balance. Bind protein with 20ml linear gradient of 20mM Na 2 HPO 4 , pH 9.0 / 40% acetonitrile for elution. Fractions of 1 ml were collected and analyzed by SDS-PAGE. The clipped hGH molecules elute before intact GH molecules (Figure 2). Obtain human growth hormone in a highly pure form. (purity: >99.5%, yield: 85%)
Embodiment 3
[0089] Addition of K to the ion-exchange purified fraction of hGH 2 HPO 4 The final concentration is 0.4M. Inject it into a 1ml Resource phenyl column (30×6.4mm) with 20mM Na 2 HPO 4 / 0.4M K 2 HPO 4 , pH9.0 balance. Bind protein with 20ml linear gradient of 20mM Na 2 HPO 4 , pH 9.0 / 30% acetonitrile for elution. Fractions of 1 ml were collected and analyzed by SDS-PAGE. This clipped hGH molecule was not resolved from the intact molecule (Figure 3).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 